A Study of AZD0466 in Patients with Advanced Hematologic or Solid Tumors

Trial Identifier:	D8240C00003
Sponsor:	AstraZeneca
NCTID::	NCT04214093
Start Date:	December 2019
Primary Completion Date:	June 2021
Study Completion Date:	June 2021
Condition:	Cancer - Other; Lymphoma; Myeloma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, TN	Nashville, TN, United States of America, 37203
United States of America, TX	Houston, TX, United States of America, 77030

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.